Water-soluble TiO2-metal hybrid nanoparticles engineered for visible-light-driven antimicrobial action. By incorporating metals such as Fe, Mn, or Al into TiO2, the nanoparticles extend light absorption into the visible spectrum and generate reactive radicals that enable efficient disinfection for consumer and industrial products.
This research offers a novel class of water-soluble TiO2-metal hybrid nanoparticles designed to overcome the key limitation of conventional TiO2 photocatalysts: their inability to operate under visible light. By integrating metal components (such as Fe, Mn, or Al) into the TiO2 host structure, the nanoparticles achieve strong visible-light absorption and efficiently channel that energy to surface metal sites, where reactive oxygen species (hydroxyl and superoxide anion radicals) are produced. These radicals provide powerful antimicrobial and disinfection effects, opening the door to light-activated antimicrobial solutions for consumer products, water treatment, healthcare surfaces, and other applications where UV-based systems are impractical.
The technology is at an early-to-mid stage of development. Initial water-based colloidal synthesis of TiO2-metal hybrid nanoparticles has been demonstrated, with confirmed visible-light absorption and efficient photocatalytic radical generation validated through transient absorption spectroscopy. Future work will focus on optimizing one-step synthesis, tuning metal composition and loading, systematically evaluating photocatalytic efficiency, and conducting antimicrobial assays to validate disinfection performance. The projected timeline is approximately one year, with about six months dedicated to synthesis development and optimization. The research team is actively seeking partnerships for materials fabrication and characterization, mechanistic studies, antimicrobial testing, and funding support for key personnel.
Brown University is a private Ivy League research university in Providence with broad disciplinary breadth and a culture of open, collaborative inquiry. Industry engagement is enabled by shared core facilities and co-located labs, structured mechanisms for corporate-sponsored research, and an urban innovation district within walking distance of campus. Clinical translation is supported through the medical school’s network of affiliated hospitals across the region. Research is backed by competitive federal funding from NIH, NSF, DoD, and other agencies, alongside state and industry partnerships. A dedicated technology transfer and corporate engagement office supports IP strategy, licensing, sponsored research agreements, and startup formation.